Science & technology | Genetic disease

Full-genome screening for newborn babies is now on the cards

A boon for medicine. But it raises questions of privacy

OVER THE years, doctors have described more than 7,000 rare diseases, generally defined as those affecting fewer than one in 2,000 people. So, though individually unusual, such illnesses are collectively a serious problem—a long-tail of need which is hard to treat because patients are few in number and their symptoms often picked up too late. Three-quarters of rare diseases are genetic, and Global Genes, an American advocacy group, reckons 400m people around the world are affected by them. For medicine to do better, people with them need to be noticed earlier, preferably in the first days of their lives.

This article appeared in the Science & technology section of the print edition under the headline “Building the future of screening”

India’s moment: Will Modi blow it?

From the May 14th 2022 edition

Discover stories from this section and more in the list of contents

Explore the edition

More from Science & technology

A person sleeping. The frame is split between night and day.

Does melatonin work for jet lag?

It can help. But it depends where you’re going

A network of pixelated hearts

Training AI models might not need enormous data centres

Eventually, models could be trained without any dedicated hardware at all


Workers harnessed unto the facade of the Museum of the Future, United Arab Emirates.

How the Gulf’s rulers want to harness the power of science

A stronger R&D base, they hope, will transform their countries’ economies. Will their plan work?


Cancer vaccines are showing promise at last

Trials are under way against skin, brain and lung tumours

New firefighting tech is being trialled in Sardinia’s ancient forests

It could sniff out blazes long before they spread out of control

Can Jeff Bezos match Elon Musk in space?

After 25 years, Blue Origin finally heads to orbit, and hopes to become a contender in the private space race